Immunoassay for detection of mutant P53 polypeptide in serum
US6083709A · kind A · utility
14Cited by
5References
50Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 23, 1993 |
| Grant date | Jul 4, 2000 |
| Priority date | — |
| Expiry date | Nov 23, 2013 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention provides a method for diagnosing in a subject a neoplastic condition which comprises (a) obtaining from the subject a sample of a biological fluid; and (b) detecting the presence in the sample of a mutant p53 polypeptide encoded by an activated p53 oncogene, the presence of the mutant p53 polypeptide in the sample indicating that the subject has the neoplastic condition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.